This article is taken from European Biopharmaceutical Review October 2018, pages 38-45. © Samedan Ltd
With an increasing number of antibody-based therapeutics entering the clinic, the need for validated anti-idiotypic reagents for use in regulatory pharmacokinetic assays is concurrently growing.
Download the full PDF article here.